267 related articles for article (PubMed ID: 21432762)
21. Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine.
Hendrickson DJ; Blumberg DA; Joad JP; Jhawar S; McDonald RJ
Pediatr Infect Dis J; 2008 Nov; 27(11):1030-2. PubMed ID: 18845981
[TBL] [Abstract][Full Text] [Related]
22. [Pneumococcal vaccination and serotype replacement: Do we need new vaccination concepts?].
Kenzel S; Hufnagel M; Berner R; Henneke P
Dtsch Med Wochenschr; 2010 Jun; 135(23):1198-200. PubMed ID: 20480453
[No Abstract] [Full Text] [Related]
23. Capsules, clones, and curious events: pneumococcus under fire from polysaccharide conjugate vaccine.
Long SS
Clin Infect Dis; 2005 Jul; 41(1):30-4. PubMed ID: 15937759
[No Abstract] [Full Text] [Related]
24. Effect of pneumococcal polysaccharide vaccine on nonbacteremic pneumococcal pneumonia.
Weiser JN; Austrian R
Clin Infect Dis; 2007 Apr; 44(8):1139-40; author reply 1140-1. PubMed ID: 17366469
[No Abstract] [Full Text] [Related]
25. Replacement pneumococcal disease in perspective.
Pelton SI
Clin Infect Dis; 2008 May; 46(9):1353-5. PubMed ID: 18419435
[No Abstract] [Full Text] [Related]
26. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines.
Picazo JJ
Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():4-6. PubMed ID: 19366362
[TBL] [Abstract][Full Text] [Related]
27. New vaccines for the prevention of pneumococcal infections.
Käyhty H; Eskola J
Emerg Infect Dis; 1996; 2(4):289-98. PubMed ID: 8969245
[TBL] [Abstract][Full Text] [Related]
28. Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?
van Werkhoven CH
Hum Vaccin Immunother; 2017 May; 13(5):1177-1181. PubMed ID: 27937061
[TBL] [Abstract][Full Text] [Related]
29. Pneumococcal meningitis still with us in the era of conjugate vaccines.
Peltola V
Acta Paediatr; 2010 Nov; 99(11):1600-1. PubMed ID: 20678164
[No Abstract] [Full Text] [Related]
30. Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation.
Ispahani P; Slack RC; Donald FE; Weston VC; Rutter N
Arch Dis Child; 2004 Aug; 89(8):757-62. PubMed ID: 15269078
[TBL] [Abstract][Full Text] [Related]
31. Serotype 19A Bacteremic Pneumococcal Pneumonia After 4 Doses of 13-Valent Conjugate Vaccine: A Review of Pneumococcal Conjugate Vaccine Effectiveness.
Iroh Tam PY; Hanisch BR; Forward B
Clin Pediatr (Phila); 2015 Jun; 54(6):591-3. PubMed ID: 25500500
[TBL] [Abstract][Full Text] [Related]
32. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006.
Motlova J; Benes C; Kriz P
Epidemiol Infect; 2009 Apr; 137(4):562-9. PubMed ID: 18796171
[TBL] [Abstract][Full Text] [Related]
33. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.
Isaacman DJ; McIntosh ED; Reinert RR
Int J Infect Dis; 2010 Mar; 14(3):e197-209. PubMed ID: 19700359
[TBL] [Abstract][Full Text] [Related]
34. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
[TBL] [Abstract][Full Text] [Related]
35. [Indirect, population effect of mass pneumococcal vaccinations (PCV7) on all-cause pneumonia incidence in Kielce, Poland].
Patrzałek M; Albrecht P; Sobczyński M
Przegl Epidemiol; 2011; 65(1):51-6. PubMed ID: 21735836
[TBL] [Abstract][Full Text] [Related]
36. Expected benefits of pneumococcal vaccination in Canadian infants and children < 5 years old.
Can Commun Dis Rep; 2006 Mar; 32(5):45-54. PubMed ID: 16649291
[No Abstract] [Full Text] [Related]
37. Global epidemiology of pneumococcal disease--new prospects for vaccine control.
Antao VC; Hausdorff WP
Adv Exp Med Biol; 2009; 634():19-29. PubMed ID: 19280845
[No Abstract] [Full Text] [Related]
38. Impact of conjugate pneumococcal vaccines on the changing epidemiology of pneumococcal infections.
Zangeneh TT; Baracco G; Al-Tawfiq JA
Expert Rev Vaccines; 2011 Mar; 10(3):345-53. PubMed ID: 21434802
[TBL] [Abstract][Full Text] [Related]
39. The significance of serotype replacement for pneumococcal disease and antibiotic resistance.
Klugman KP
Adv Exp Med Biol; 2009; 634():121-8. PubMed ID: 19280854
[No Abstract] [Full Text] [Related]
40. Pneumococcal Conjugate Vaccine Impact on Meningitis and Pneumonia Among Children Aged <5 Years-Zimbabwe, 2010-2016.
Dondo V; Mujuru H; Nathoo K; Jacha V; Tapfumanei O; Chirisa P; Manangazira P; Macharaga J; de Gouveia L; Mwenda JM; Katsande R; Weldegebriel G; Pondo T; Matanock A; Lessa FC
Clin Infect Dis; 2019 Sep; 69(Suppl 2):S72-S80. PubMed ID: 31505631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
